Targeting the MHC Ligandome by Use of TCR-Like Antibodies

Monoclonal antibodies (mAbs) are valuable as research reagents, in diagnosis and in therapy. Their high specificity, the ease in production, favorable biophysical properties and the opportunity to engineer different properties make mAbs a versatile class of biologics. mAbs targeting peptide&#872...

Full description

Bibliographic Details
Main Authors: Lene Støkken Høydahl, Rahel Frick, Inger Sandlie, Geir Åge Løset
Format: Article
Language:English
Published: MDPI AG 2019-05-01
Series:Antibodies
Subjects:
MHC
Online Access:https://www.mdpi.com/2073-4468/8/2/32